Author: Simões e Silva, Ana Cristina; Lanza, Katharina; Palmeira, Vitória Andrade; Costa, Larissa Braga; Flynn, Joseph T.
Title: 2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus Cord-id: sgts963l Document date: 2020_9_29
ID: sgts963l
Snippet: The last decade was crucial for our understanding of the renin–angiotensin–aldosterone system (RAAS) as a two-axis, counter-regulatory system, divided into the classical axis, formed by angiotensin-converting enzyme (ACE), angiotensin II (Ang II), and the angiotensin type 1 receptor (AT1R), and the alternative axis comprising angiotensin-converting enzyme 2 (ACE2), angiotensin-(1-7) (Ang-(1-7)), and the Mas receptor. Breakthrough discoveries also took place, with other RAAS endopeptides bein
Document: The last decade was crucial for our understanding of the renin–angiotensin–aldosterone system (RAAS) as a two-axis, counter-regulatory system, divided into the classical axis, formed by angiotensin-converting enzyme (ACE), angiotensin II (Ang II), and the angiotensin type 1 receptor (AT1R), and the alternative axis comprising angiotensin-converting enzyme 2 (ACE2), angiotensin-(1-7) (Ang-(1-7)), and the Mas receptor. Breakthrough discoveries also took place, with other RAAS endopeptides being described, including alamandine and angiotensin A. In this review, we characterize the two RAAS axes and the role of their components in pediatric kidney diseases, including childhood hypertension (HTN), pediatric glomerular diseases, congenital abnormalities of the kidney and urinary tract (CAKUT), and chronic kidney disease (CKD). We also present recent findings on potential interactions between the novel coronavirus, SARS-CoV-2, and components of the RAAS, as well as potential implications of coronavirus disease 2019 (COVID-19) for pediatric kidney diseases.
Search related documents:
Co phrase search for related documents- abdominal fat and adipose tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- abdominal fat and liver disease: 1, 2, 3
- abdominal fat and liver fibrosis: 1
- abdominal fat and liver function: 1, 2, 3
- abdominal fat and liver injury: 1, 2
- abdominal pain and acute aki kidney injury: 1, 2, 3, 4, 5, 6
- abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
- abdominal pain and acute myocardial infarction: 1, 2, 3, 4, 5, 6
- abdominal pain and adipose tissue: 1, 2, 3
- abdominal pain and adrenal gland: 1, 2
- abdominal pain and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- abdominal pain and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- abdominal pain and low incidence: 1, 2, 3
- abdominal pain and lung infection: 1, 2, 3, 4
- abdominal pain and lung inflammation: 1
- abdominal pain and lung injury: 1, 2, 3, 4, 5
- abdominal pain and lung tissue: 1, 2
- abdominal pain and macrophage activation: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date